Exploring Provenge Gets Fda Approval
Exploring Provenge Gets Fda Approval reveals several interesting facts.
- Host: Bruce Japsen Guest: Mark Frohlich, MD The cancer treatment
- PCRI's Executive Director, Mark Scholz, MD, explains why
- The first therapeutic cancer vaccine,
- Robert S. Alter, MD, co-chief, Urologic Oncology, John Theurer Cancer Center, discusses the 3 day process involved in the ...
- Philip Kantoff, MD, explains why the prostate cancer vaccine
In-Depth Information on Provenge Gets Fda Approval
The first therapeutic cancer vaccine, PCRI's Executive Director, Mark Scholz, MD, describes Alex and Dr. Scholz discuss which patients are eligible to have Evaluating men for prostate cancer recurrence has long been a major challenge; physicians have had to wait until a patient's ...
Sipuleucel-T (Provenge®): The First FDA-Approved Therapeutic Cancer Vaccine for Prostate Cancer
Stay tuned for more updates related to Provenge Gets Fda Approval.